← All trials
NCT04430530
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2020
- Primary completion
- May 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Jun 12, 2020
- Last posted
- Jun 12, 2020
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Shenzhen Geno-Immune Medical InstituteLead sponsor
- Shenzhen UniversityCollaborator
- ShiJiaZhuang Zhongxi Children HospitalCollaborator
- Sun Yat-Sen UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.